---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-021320"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-22T23:37:25.319208+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Baxter Q1 beats: sales $2.63B, adj. EPS $0.55; FY guidance raised to $2.47-$2.55

## Summary
- First-quarter sales $2.63B, up 5% reported and operational, exceeding guidance.
- GAAP diluted EPS from continuing ops $0.13; adjusted diluted EPS $0.55, both above guidance.
- Full-year 2025 adjusted EPS guidance raised: lower end increased to $2.47-$2.55 range.
- Chair and interim CEO Brent Shafer cites transformation progress and focus on essential medtech.
- Management notes global macroeconomic uncertainty but remains confident in trajectory.

## SEC filing metadata
- accession: 0001628280-25-021320
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828025021320/0001628280-25-021320-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828025021320/bax-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-021320
- JSON: https://secwatch.observer/filing/0001628280-25-021320.json
- Plain text: https://secwatch.observer/filing/0001628280-25-021320.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.